Trypan Blue
Other Surgical Aids
Sold as VISIONBLUE · MEMBRANEBLUE
- Drug class
- Other Surgical Aids
- Availability
- Prescription only
- Routes
- Intraocular, Ophthalmic
- Markets covered
- 2
- Products on record
- 2
- FDA reports (12 mo)
- 1
Overview
Plain-language summary, compiled from the cited regulatory records
Trypan Blue is an active ingredient classified as an Other Surgical Aid [1]. It is approved for use as a staining agent in ophthalmic surgery. Specifically, it is indicated to stain epiretinal membranes during vitrectomy procedures, which helps in the removal of this tissue [1]. This application is for both adult and pediatric patients undergoing these specific eye surgeries [1].
Trypan Blue is available under various brand names, including MEMBRANEBLUE [1]. In the past 12 months, there has been one adverse event report associated with this active ingredient [2]. The most frequently reported adverse reaction in these reports was Corneal Decompensation [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | November 24, 2025 |
| CA Canada | Health Canada | 1 | March 22, 2025 |
USUnited States· FDA
1 product
Uses
15% is indicated for use as an aid in ophthalmic surgery by staining the epiretinal membranes during ophthalmic surgical vitrectomy procedures, facilitating removal of the tissue in adults and pediatric patients. These highlights do not include all the information needed to use MEMBRANEBLUE™ safely and effectively.
See full prescribing information for MEMBRANEBLUE. S. Approval: 2004 MembraneBlue is a diagnostic dye indicated for use as an aid in ophthalmic posterior surgery by staining the epiretinal membranes during ophthalmic surgical vitrectomy procedures, facilitating removal of epiretinal tissue in adults and pediatric patients
How to take
CACanada· Health Canada
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Brands in Canada (1)
Sources & citations
- [1]FDA DailyMed · 0364aceb-dd3f-4b… · revised November 24, 2025 [PDF]
- [2]Health Canada (DPD) · 02279525 · revised March 22, 2025
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.